biosimilars

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

Sandoz expands biosimilar collaboration with Samsung Bioepis

Mar 18, 2026 11:05am

Sandoz to break its biosimilars business out from generics

Mar 10, 2026 4:01pm

FDA drafts plan to cut down on biosimilar testing requirements

Mar 9, 2026 5:25pm

Bayer's pharma division sees one more year of declining sales

Mar 4, 2026 11:35am

Lilly-Innovent, AstraZeneca, Madrigal—Fierce Pharma Asia

Feb 13, 2026 8:25am